Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Aarons

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Pharmaceutical Statistics|August 29, 2009
Sample-size calculations for multi-group comparison in population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|September 10, 2008
Optimisation of sampling windows design for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 11, 2014
A physiologically based pharmacokinetic model for Valproic acid in adults and childrenKayode Ogungbenro, Leon Aarons,
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2010
Founding figures of pharmacokinetics: tribute to Malcolm RowlandLeon Aarons, Leslie Z Benet
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect dataGordon Graham, Suneel Gupta, Leon Aarons
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Journal of Pharmacokinetics and Pharmacodynamics|July 1, 2006
Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGSIvelina Gueorguieva, Leon Aarons, Malcolm Rowland
Pharmaceutical Research|April 2, 2013
A physiologically based pharmacokinetic model for strontium exposure in ratHenry Pertinez, Marylore Chenel, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|January 25, 2012
Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9Kerenaftali Klein, Ivelina Gueorguieva, Leon Aarons
The Journal of Pharmacy and Pharmacology|February 22, 2005
A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studiesLynne Evans, Leon Aarons, Chris Brearley
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Pharmaceutical Statistics|August 29, 2009
Sample-size calculations for multi-group comparison in population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|September 10, 2008
Optimisation of sampling windows design for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 11, 2014
A physiologically based pharmacokinetic model for Valproic acid in adults and childrenKayode Ogungbenro, Leon Aarons,
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2010
Founding figures of pharmacokinetics: tribute to Malcolm RowlandLeon Aarons, Leslie Z Benet
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect dataGordon Graham, Suneel Gupta, Leon Aarons
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Journal of Pharmacokinetics and Pharmacodynamics|July 1, 2006
Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGSIvelina Gueorguieva, Leon Aarons, Malcolm Rowland
Pharmaceutical Research|April 2, 2013
A physiologically based pharmacokinetic model for strontium exposure in ratHenry Pertinez, Marylore Chenel, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|January 25, 2012
Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9Kerenaftali Klein, Ivelina Gueorguieva, Leon Aarons
The Journal of Pharmacy and Pharmacology|February 22, 2005
A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studiesLynne Evans, Leon Aarons, Chris Brearley
Pageof 13